drugset / Trial / NCT04900948
Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life
Phase 4
Completed
108 enrolled
National Medical Research Center for Children's Health, Russian Federation
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This experimental non-randomized clinical study is aimed at comparing the efficacy and safety assessment of the proposed topical therapy algorithms with the use of topical calcineurin inhibitors in reducing the severity of atopic dermatitis and the degree of development of transcutaneous sensitization in children of the first year of life.
Timeline
- Start
- 2017-12-10
- Primary completion
- 2020-04-25
- Completion
- 2020-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pimecrolimus | Small molecule | 1 % | Topical |
| Comparator | methylprednisolone aceponate | Small molecule | 0.1 % | Topical |